Proto Labs: Outpacing The Market Could Be The Norm Going Forward
Proto Labs receives a Buy rating, driven by robust Q2 results and accelerating operating leverage. PRLB's CNC Machining and Injection Molding segments are outpacing industry CAGRs, signaling sustained market share gains. Gross margins are recovering, aided by a strategic focus on higher-value contracts and improved network fulfillment economics.















